Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2023
9-1-2023 Achenbach Syndrome in a Patient with Raynaud's Phenomenon, Massiel E. Jimenez, Rochester Regional Health and Anthony Ocon, Rochester Regional Health
9-1-2023 Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children, Marie Bastin, DNAlytics, Ottignies-Louvain-la-Neuve, Belgium., Warner W. Carr, Allergy and Asthma Associates of Southern California, Southern California Research, California, Mission Viejo, USA., Carla M. Davis, Department of Pediatrics, Immunology, Allergy, and Retrovirology Division, Baylor College of Medicine, Houston, Texas, USA., et al.
9-1-2023 The Penicillin Allergy Decision Rule-Something New for Penicillin Allergy, Allison Ramsey, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
8-1-2023 Treating Common Variable Immunodeficiency With Subcutaneous Immunoglobulin: A Challenge With Several Social Determinants of Health, Roshan Subedi, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health
8-1-2023 Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach, Matthew Greenhawt, Timothy E Dribin, Elissa M Abrams, et al.
6-1-2023 Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins, Tooba Salar, Rochester Regional Health, Massiel Jimenez, Rochester Regional Health, Mazin Hameed, Rochester Regional Health, et al.
6-1-2023 Steroid-induced secondary immune deficiency, S Shahzad Mustafa, Rochester Regional Health
5-11-2023 Updates in Asthma, Sara Patrawala, Rochester Regional Health
5-1-2023 The need for change: Lessons learned from Food and Drug Administration-approved peanut oral immunotherapy, S Shahzad Mustafa, Rochester Regional Health and Douglas P. Mack, McMaster University, Hamilton, Ontario, Canada.
4-1-2023 Food allergy and travel: Is it time to establish best practice parameters?, Irene Yuan, Vanderbilt University Medical Center, Nashville, Tennessee. and Peter Capucilli, Rochester Regional Health
3-1-2023 Real-World Experience of Tixagevimab and Cilgavimab (Evusheld) in Rheumatologic Patients on Rituximab, Anthony J. Ocon, Rochester Regional Health and S. Shahzad Mustafa, Rochester Regional Health
3-2023 Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma: Recommendations from an international expert panel, Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Sergio Giralt, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Tessa Kerre, Faculty of Medicine and Health Sciences, Ghent University Hospital, Ghent, Belgium., et al.
2-15-2023 Structure and IgE Cross-Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin-Buried Peptides, Alexander C. Foo, Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, MD-MR01, Durham, North Carolina 27709, United States., Jacqueline B. Nesbit, Agricultural Research Service, United States Department of Agriculture, 1100 Allen Toussaint Boulevard, New Orleans, Louisiana 70124, United States., Stephen A. Gipson, Agricultural Research Service, United States Department of Agriculture, 1100 Allen Toussaint Boulevard, New Orleans, Louisiana 70124, United States., et al.
2-7-2023 Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review, Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Sergio Giralt, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Tessa Kerre, Faculty of Medicine and Health Sciences, Ghent University Hospital, Ghent, Belgium., et al.
2-1-2023 A Randomized Trial of Penicillin Skin Testing Versus 2-Step Direct Challenge for Penicillin Allergy During Pregnancy, Allison Ramsey, Rochester Regional Health and S. Shahzad Mustafa, Rochester Regional Health
2-1-2023 Comparisons of Structure, Stability, and IgE Cross-Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin-Buried Peptides, Alexander Foo, National Institute of Environmental Health, Jacqueline Nesbit, USDA, Stephen Gipson, USDA SRRC, et al.
2-1-2023 Drug Allergy Assessments in Older Adults: A Multi-Site Prospective Study from the United States Drug Allergy Registry, John Accarino, Massachusetts General Hospital, Allison Ramsey, Rochester Regional Health, Upeka Samarakoon, Massachusetts General Hospital, et al.
2-1-2023 Outcome of Electronic-Consults and Facilitated Follow-up for Inpatient Asthma Exacerbations, Linh-An Tuong, Rochester Regional Health, Allison Ramsey, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, et al.
2-1-2023 Peanut (Arachis hypogaea) Allergen Powder-dnfp Manufacturing Including Standardization Of Allergen Potency, Stephen Tilles, Aimmune Therapeutics, a Nestlé Health Science company, Stephanie Leonard, University of California San Diego, Rady Children's Hospital, Paul T. Jedrzejewski, Medical Affairs, Aimmune Therapeutics, a Nestlé Health Science company, Brisbane, CA, United States., et al.
1-1-2023 Management of secondary immunodeficiency in hematological malignancies in the era of modern oncology, Nina Shah, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.; S Shahzad Mustafa, Rochester Regional Health; and Donald C. Vinh, Department of Medicine, McGill University Health Centre, Montreal, Canada.
1-1-2023 Teleallergy: Where Have We Been and Where Are We Going?, Allison Ramsey, Rochester Regional Health, Ann Chen Wu, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass., Bruce G. Bender, National Jewish Health, Denver, Colo., et al.
1-1-2023 Transitioning individuals with peanut allergy from US Food and Drug Administration-approved peanut oral immunotherapy to a dietary peanut product, S Shahzad Mustafa, Rochester Regional Health and Jodi Shroba, Allergy and Immunology, Children's Mercy Hospital, Kansas City, Missouri.
Submissions from 2022
12-1-2022 Bringing Data to Bear on the Mushy Middle: Riskier Immediate Reactions to Penicillin, Cosby A. Stone, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. and Allison Ramsey, Rochester Regional Health
12-1-2022 Effects of oral immunotherapy on immune tolerance, Peter Capucilli, Rochester Regional Health and David A. Hill, Division of Allergy and Immunology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics and Institute for Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
12-1-2022 Immunosuppression in Patients With Primary Immunodeficiency-Walking the Line, S Shahzad Mustafa, Rochester Regional Health; Nicholas L. Rider, Liberty University College of Osteopathic Medicine and the Liberty Mountain Medical Group, Lynchburg, Va.; and Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom.